Children with autism have no unique pattern of abnormal results on endoscopy or other tests for gastrointestinal (GI) disorders, compared to non-autistic children with GI symptoms, reports a study in the Journal of Pediatric Gastroenterology and Nutrition (JPGN), official journal of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. The journal is published by Wolters Kluwer.
The study finds no evidence of cellular intestinal inflammation, lactase deficiency, or "leaky gut" specific to autistic children with GI symptoms, according to the new research, led by Timothy Buie, MD, Rafail Kushak, PhD, and Harland Winter, MD, of MassGeneral Hospital for Children, Boston. The results raise questions about previous scientific and non-scientific reports linking GI abnormalities to autism and autistic behaviors.
Similar Findings in Autistic versus 'Neurotypical' Children with GI Symptoms
The researchers analyzed the results of diagnostic tests in 61 children with autism being evaluated for GI symptoms, such as abdominal pain or constipation. The findings were compared with those in 50 non-autistic, or "neurotypical," children undergoing similar tests. All tests were performed as part of routine clinical care—not solely for the purposes of the study.
The study focused on certain abnormalities with previously suggested links to autism. These include intestinal inflammation; deficiency of the digestive enzyme lactase, associated with lactose intolerance; and increased intestinal permeability, sometimes called "leaky gut."
Intestinal biopsy samples showed mild levels of microscopic inflammation in some of the children with autism, as well as in some of the non-autistic children. Markers of intestinal inflammation, lactase deficiency, and intestinal permeability were all similar between the children with and without autism.
Children with autism have behaviors that affect social interaction and both verbal and nonverbal communication. Common problems such as acid reflux or constipation may lead to atypical symptoms in children with autism—for example, aggressive or self-injuring behavior. "Consequently, gastrointestinal problems that might easily be recognized in a neurotypical child may go undiagnosed in a child with autism," the researchers write.
These unusual symptoms have led to the suggestion that autism behaviors might be linked to underlying GI disorders—or even that GI abnormalities contribute to the development of autism. Some parents and clinicians have observed improvements in autism-related behaviors and GI symptoms with special diets and other "non-evidence based interventions."
But the new study questions the reported links between autism and GI abnormalities, showing no significant differences in intestinal inflammation, lactase deficiency, or intestinal permeability in autistic versus non-autistic children with GI symptoms. "The results of this study suggest that common gastrointestinal problems occur in children with autism and should be evaluated," according to the authors. They add, "There is no evidence to support that gastrointestinal disorders cause autism."
The researchers emphasize that the findings of endoscopy and other diagnostic tests in autistic children with GI symptoms are similar to those in nonautistic children with similar GI symptoms. However, they note, "Identifying children with ASD who have concomitant medical conditions such as inflammatory bowel disease, malabsorption, or lactose intolerance may be challenging because their symptoms are atypical."
Article: "Evaluation of Intestinal Function in Children with Autism and Gastrointestinal Symptoms" (doi: doi: 10.1097/MPG.0000000000001174)
Journal of Pediatric Gastroenterology and Nutrition
The Journal of Pediatric Gastroenterology and Nutrition provides a forum for original papers and reviews dealing with pediatric gastroenterology and nutrition, including normal and abnormal functions of the alimentary tract and its associated organs, including the salivary glands, pancreas, gallbladder, and liver. Particular emphasis is on development and its relation to infant and childhood nutrition.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.